Scott Henry
Stock Analyst at Alliance Global Partners
(1.32)
# 3,594
Out of 4,996 analysts
52
Total ratings
41.51%
Success rate
-4.1%
Average return
Main Sectors:
Stocks Rated by Scott Henry
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TNON Tenon Medical | Initiates: Buy | $3 | $1.18 | +154.24% | 1 | Apr 9, 2025 | |
| QSI Quantum-Si incorporated | Initiates: Buy | $3.75 | $1.49 | +151.68% | 1 | Feb 7, 2025 | |
| VVOS Vivos Therapeutics | Maintains: Buy | $8.25 → $6 | $3.12 | +92.31% | 4 | Nov 19, 2024 | |
| LPCN Lipocine | Initiates: Buy | $10 | $2.73 | +266.30% | 1 | Sep 24, 2024 | |
| ASRT Assertio Holdings | Initiates: Buy | $2.75 | $0.89 | +210.73% | 1 | May 28, 2024 | |
| DERM Journey Medical | Initiates: Buy | $8.5 | $7.04 | +20.76% | 2 | Feb 16, 2024 | |
| RNXT RenovoRx | Initiates: Buy | $4 | $1.18 | +238.98% | 3 | Feb 2, 2024 | |
| FBIO Fortress Biotech | Maintains: Buy | $30 → $15 | $3.91 | +283.63% | 2 | Nov 29, 2023 | |
| RVPH Reviva Pharmaceuticals Holdings | Reiterates: Buy | $12 | $0.30 | +3,967.80% | 2 | Oct 30, 2023 | |
| CSBR Champions Oncology | Maintains: Buy | $9 → $7.5 | $6.30 | +19.05% | 2 | Sep 22, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $10 → $13 | $10.75 | +20.99% | 4 | Aug 16, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $19 → $24 | $25.57 | -6.14% | 2 | May 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | $10 → $16 | $19.52 | -20.59% | 2 | Aug 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $55 → $58 | $84.19 | -31.11% | 6 | Aug 3, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $36 | $70.27 | -48.77% | 1 | Aug 2, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $9 → $11 | $1.15 | +856.52% | 3 | May 12, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 → $6 | $3.10 | +93.55% | 2 | Feb 26, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $6,000 → $5,750 | $2.19 | +262,457.08% | 1 | Feb 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $1.66 | - | 1 | Dec 4, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | $7 | $0.93 | +651.80% | 3 | Nov 11, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Buy | n/a | $24.21 | - | 5 | Apr 18, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $2.19 | - | 2 | Mar 26, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $4.15 | - | 1 | Nov 10, 2017 |
Tenon Medical
Apr 9, 2025
Initiates: Buy
Price Target: $3
Current: $1.18
Upside: +154.24%
Quantum-Si incorporated
Feb 7, 2025
Initiates: Buy
Price Target: $3.75
Current: $1.49
Upside: +151.68%
Vivos Therapeutics
Nov 19, 2024
Maintains: Buy
Price Target: $8.25 → $6
Current: $3.12
Upside: +92.31%
Lipocine
Sep 24, 2024
Initiates: Buy
Price Target: $10
Current: $2.73
Upside: +266.30%
Assertio Holdings
May 28, 2024
Initiates: Buy
Price Target: $2.75
Current: $0.89
Upside: +210.73%
Journey Medical
Feb 16, 2024
Initiates: Buy
Price Target: $8.5
Current: $7.04
Upside: +20.76%
RenovoRx
Feb 2, 2024
Initiates: Buy
Price Target: $4
Current: $1.18
Upside: +238.98%
Fortress Biotech
Nov 29, 2023
Maintains: Buy
Price Target: $30 → $15
Current: $3.91
Upside: +283.63%
Reviva Pharmaceuticals Holdings
Oct 30, 2023
Reiterates: Buy
Price Target: $12
Current: $0.30
Upside: +3,967.80%
Champions Oncology
Sep 22, 2023
Maintains: Buy
Price Target: $9 → $7.5
Current: $6.30
Upside: +19.05%
Aug 16, 2023
Maintains: Buy
Price Target: $10 → $13
Current: $10.75
Upside: +20.99%
May 3, 2023
Maintains: Buy
Price Target: $19 → $24
Current: $25.57
Upside: -6.14%
Aug 24, 2022
Downgrades: Neutral
Price Target: $10 → $16
Current: $19.52
Upside: -20.59%
Aug 3, 2021
Maintains: Neutral
Price Target: $55 → $58
Current: $84.19
Upside: -31.11%
Aug 2, 2021
Maintains: Buy
Price Target: $32 → $36
Current: $70.27
Upside: -48.77%
May 12, 2021
Maintains: Buy
Price Target: $9 → $11
Current: $1.15
Upside: +856.52%
Feb 26, 2021
Maintains: Buy
Price Target: $4 → $6
Current: $3.10
Upside: +93.55%
Feb 16, 2021
Maintains: Buy
Price Target: $6,000 → $5,750
Current: $2.19
Upside: +262,457.08%
Dec 4, 2020
Downgrades: Neutral
Price Target: n/a
Current: $1.66
Upside: -
Nov 11, 2020
Upgrades: Buy
Price Target: $7
Current: $0.93
Upside: +651.80%
Apr 18, 2019
Upgrades: Buy
Price Target: n/a
Current: $24.21
Upside: -
Mar 26, 2018
Downgrades: Neutral
Price Target: n/a
Current: $2.19
Upside: -
Nov 10, 2017
Downgrades: Neutral
Price Target: n/a
Current: $4.15
Upside: -